tiprankstipranks
Trending News
More News >
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
US Market
Advertisement

Ocular Therapeutix (OCUL) Technical Analysis

Compare
1,448 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Ocular Therapeutix’s (OCUL) Moving Averages Convergence Divergence (MACD) indicator is -0.23, suggesting Ocular Therapeutix is a Buy.
Ocular Therapeutix’s (OCUL) 20-Day exponential moving average is 12.07, while Ocular Therapeutix’s (OCUL) share price is $11.41, making it a Sell.
Ocular Therapeutix’s (OCUL) 50-Day exponential moving average is 11.89, while Ocular Therapeutix’s (OCUL) share price is $11.41, making it a Sell.

Ocular Therapeutix (OCUL) Pivot Points

Oct 06, 2025, 09:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.13
10.38
10.72
10.97
11.31
11.56
11.90
Fibonacci
10.38
10.61
10.74
10.97
11.20
11.33
11.56
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ocular Therapeutix (OCUL) Moving Averages

Oct 06, 2025, 09:52 AM
Period
Simple
Exponential
MA5
11.55Sell
11.51Sell
MA10
11.95Sell
11.81Sell
MA20
12.28Sell
12.07Sell
MA50
12.30Sell
11.89Sell
MA100
10.70Buy
11.07Buy
MA200
9.20Buy
10.06Buy
Ocular Therapeutix’s (OCUL) 10-Day exponential moving average is 11.81, while Ocular Therapeutix’s (OCUL) share price is $11.41, making it a Sell.
Ocular Therapeutix’s (OCUL) 100-Day exponential moving average is 11.07, while Ocular Therapeutix’s (OCUL) share price is $11.41, making it a Buy.
Ocular Therapeutix’s (OCUL) stock price is $11.41 and Ocular Therapeutix’s (OCUL) 50-day simple moving average is 12.30, creating a Sell signal.
Ocular Therapeutix’s (OCUL) stock price is $11.41 and Ocular Therapeutix’s (OCUL) 100-day simple moving average is 10.70, creating a Buy signal.
Ocular Therapeutix’s (OCUL) stock price is $11.41 and Ocular Therapeutix’s (OCUL) 200-day simple moving average is 9.20, creating a Buy signal.

Ocular Therapeutix (OCUL) Technical Indicators

Oct 06, 2025, 09:52 AM
Name
Value
Implied Action
RSI (14)
41.27
Neutral
STOCH (9,6)
18.82
Buy
STOCHRSI (14)
18.49
Buy
MACD (12,26)
-0.23
Buy
ADX (14)
18.84
Buy
Williams %R
-66.67
Buy
CCI (14)
-156.69
Buy
ATR (14)
0.69
-
Ultimate Oscillator
35.00
Neutral
ROC
-9.01
Sell
Ocular Therapeutix’s (OCUL) Relative Strength Index (RSI) is 41.27, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Trend Strength Indicator (ADX) is 18.84, creating a Buy signal.
Ocular Therapeutix’s (OCUL) Commodity Channel Index (CCI) is -156.69, creating a Buy signal.
Ocular Therapeutix’s (OCUL) Price Rate of Change (ROC) is -9.01, creating a Sell signal.

FAQ

Is OCUL a Buy, Hold, or Sell?
Based on OCUL’s technical indicators, OCUL is a Hold.
    What is OCUL’s RSI (14)?
    OCUL’s RSI (14) is 41.27, which suggests OCUL is a Neutral.
      What is OCUL’s MACD?
      OCUL’s MACD is -0.23, which suggests OCUL is a Buy.
        What is OCUL’s 5-day moving average?
        OCUL’s 5-day moving average is 11.55, which suggests OCUL is a Sell.
          What is OCUL’s 20-day moving average?
          OCUL 20-day moving average is 12.28, which suggests OCUL is a Sell.
            What is OCUL’s 50-day moving average?
            OCUL’s 50-day moving average is 12.30, which suggests OCUL is a Sell.
              What is OCUL’s 200-day moving average?
              OCUL’s 200-day moving average is 9.20, which suggests OCUL is a Buy.
                What is OCUL’s Williams % R (14)?
                OCUL’s Williams % R (14) is -66.67, which suggests OCUL is a Buy.
                  What is OCUL’s CCI (14)?
                  OCUL’s CCI (14) is -156.69, which suggests OCUL is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis